SCHEMBL30433944

SCHEMBL30433944

COc1ncc(F)cc1C1(C(=O)O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLQ O75417 1/20 0.35
HDAC4 P56524 4/20 0.35
AGBL2 Q5U5Z8 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.33
AKR1C3 P42330 2/20 0.33
AKR1C2 P52895 2/20 0.33
BACE1 P56817 2/20 0.33
SSTR4 P31391 1/20 0.33
APP P05067 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SCN9A Q15858 1/20 0.32
ELOVL1 Q9BW60 1/20 0.32
GRM5 P41594 1/20 0.32
RAF1 P04049 1/20 0.32
BRAF P15056 1/20 0.32
AKR1B10 O60218 1/20 0.32
AKR1C4 P17516 1/20 0.32
AKR1C1 Q04828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21408257 1.00 POLQ (0.35) POLQHDAC4AGBL2GPBAR1AKR1C3
SCHEMBL20790000 0.84 SLC13A5 (0.40) HDAC4BACE1SSTR4
SCHEMBL20790246 0.82 LMNA (0.40) AGBL2AKR1C3AKR1C2APPRAF1
SCHEMBL31444975 0.80 AGBL2 (0.41) HDAC4AGBL2AKR1C3AKR1C2APP
SCHEMBL31446263 0.80 APP (0.36) HDAC4AGBL2AKR1C3AKR1C2APP
SCHEMBL23327795 0.79 POLQ (0.38) POLQHDAC4AGBL2GPBAR1BACE1
SCHEMBL15204492 0.77 AKR1C3 (0.38) HDAC4AGBL2AKR1C3AKR1C2APP
SCHEMBL20790131 0.77 HDAC4 (0.40) HDAC4SSTR4APPCYP3A4CYP2C9
SCHEMBL21408269 0.76 POLQ (0.34) POLQHDAC4GPBAR1BACE1SSTR4
SCHEMBL30434411 0.76 POLQ (0.34) POLQHDAC4GPBAR1BACE1SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642782-A2 ALPHA-V-BETA-8 INTEGRIN INHIBITORS AND USES THEREOF Pliant Therapeutics, Inc. (US) 2025-11-05 EP disclosed
WO-2025072539-A1 AMINO ACID COMPOUNDS WITH NITROGEN LINKERS AND USES THEREOF PLIANT THERAPEUTICS, INC. (US) 2025-04-03 WO disclosed
CN-111971287-B Macrocyclic compounds as TRK kinase inhibitors 重庆复尚源创医药技术有限公司 2023-06-02 CN disclosed